nominally significantP = 0.013
Separate analyses of class 2 and 3 mutations independently showed nominally significant positive selection of BRAF in MSS tumors for both classes (dN/dS = 7.21; P = 0.013 and dN/dS = 8.51; P = 0.005, respectively).
Separate analyses of class 2 and 3 mutations independently showed nominally significant positive selection of BRAF in MSS tumors for both classes (dN/dS = 7.21; P = 0.013 and dN/dS = 8.51; P = 0.005, respectively).
There was also a borderline significant difference observed between class 2 and class 3 BRAF -mutant colorectal cancers (frequencies 16.1% and 35.8%, respectively; P = 0.06, Fisher exact test; Table 1 ).